Technological Intervention for Reducing Alcohol Use Among People Living With HIV/AIDS
| Status: | Not yet recruiting |
|---|---|
| Conditions: | HIV / AIDS, HIV / AIDS, HIV / AIDS, Psychiatric |
| Therapuetic Areas: | Immunology / Infectious Diseases, Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 3/17/2019 |
| Start Date: | April 2019 |
| End Date: | July 2022 |
| Contact: | Carolyn K Lauckner, PhD |
| Email: | clauck@uga.edu |
| Phone: | 7065424447 |
A Telemedicine and mHealth Intervention for Reducing Alcohol Consumption Among People Living With HIV/AIDS
While advances in medication have led to greatly improved outcomes for people living with
HIV/AIDS, less than one-third of all people living with the disease are adherent enough to
their medication to achieve viral suppression. Alcohol consumption has been shown to have a
significant effect on HIV medication adherence, so the proposed research will aim to reduce
alcohol use among people living with HIV/AIDS through a technology-driven intervention. This
eight-session intervention will be delivered using a combination of videoconferencing, smart
phones, and Bluetooth-enabled breathalyzers for monitoring of alcohol consumption, with an
overall goal of reducing alcohol use, mitigating adherence issues, and achieving optimal
prevention and treatment responses for people living with HIV/AIDS.
HIV/AIDS, less than one-third of all people living with the disease are adherent enough to
their medication to achieve viral suppression. Alcohol consumption has been shown to have a
significant effect on HIV medication adherence, so the proposed research will aim to reduce
alcohol use among people living with HIV/AIDS through a technology-driven intervention. This
eight-session intervention will be delivered using a combination of videoconferencing, smart
phones, and Bluetooth-enabled breathalyzers for monitoring of alcohol consumption, with an
overall goal of reducing alcohol use, mitigating adherence issues, and achieving optimal
prevention and treatment responses for people living with HIV/AIDS.
Inclusion Criteria:
- HIV-positive
- 18 years or older
- At-risk drinker as identified by an AUDIT score (>= 8 for men or >=4 for women)
- Currently prescribed HIV medication
- Less than 95% adherent to their HIV medication as identified through self-report
Exclusion Criteria:
- Less than 18 years old
- Non-English Speaking
We found this trial at
1
site
Athens, Georgia 30602
Principal Investigator: Carolyn Lauckner, PhD
Phone: 706-542-4447
Click here to add this to my saved trials
